News

Can Eli Lilly Stock Withstand the Threat of President Trump's New Sweeping Tariffs?
Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
The Economist5d
Trump’s real threat: industry-specific tariffs
W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...
Biogen commits $2 billion to expand NC’s RTP campuses amid pharma tariff threat
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...
Fierce Pharma13d
Trump renews 200% tariff threat on pharmaceuticals, indicates plan for grace period
Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...
Swedish Drugmaker Sobi Doesn’t See Pharma Tariffs as ‘Imminent’
Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...
AstraZeneca unveils $64 billion US investment as as pharma tariff threat looms
The move is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry. Read more at ...